Tapestry Networks, 303 Wyman St, Ste 300, Waltham, MA 02451. Email:
Am J Manag Care. 2022 Mar;28(3):98-100. doi: 10.37765/ajmc.2022.88835.
Many payers and clinicians are committed to advancing value-based care through the establishment of alternative payment models (APMs) that incentivize practices and clinicians to improve quality and reduce cost. A multistakeholder working group has observed that in specialty fields such as oncology, despite many attempts to design and implement APM pilots for commercial and Medicare Advantage populations, practical challenges and small numbers of episodes and patients present headwinds to viability and scalability. Despite this, some payers report emerging good practices and are optimistic about APMs. Careful and realistic consideration of the specific goals of a proposed model is warranted, as is close examination of the feasibility of transferring risk.
许多支付方和临床医生致力于通过建立鼓励实践和临床医生提高质量和降低成本的基于价值的支付模式（APM）来推进价值医疗。一个多利益相关方的工作组观察到，在肿瘤学等专业领域，尽管为商业和医疗保险优势人群设计和实施 APM 试点的尝试很多，但实际挑战以及有限的病例和患者数量给其可行性和可扩展性带来了阻力。尽管如此，一些支付方还是报告了一些新兴的良好实践，并对 APM 持乐观态度。有必要对拟议模型的具体目标进行仔细和现实的考虑，同时也需要仔细研究转移风险的可行性。
